Stellar Biotechnologies Inc Stock Toronto S.E.
Equities
KLH
CA85855A2039
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 14.09M 19.2M |
---|---|---|---|---|---|
Net income 2024 * | -8M -10.9M | Net income 2025 * | -10M -13.63M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-1.56
x | P/E ratio 2025 * |
-2.63
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 71.55% |
Managers | Title | Age | Since |
---|---|---|---|
Pardeep Nijhawan
FOU | Founder | 53 | 07-06-11 |
Michael Brooks
PSD | President | 46 | 15-08-31 |
Stephen Lemieux
DFI | Director of Finance/CFO | 48 | 23-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Sean MacDonald
BRD | Director/Board Member | 47 | 19-06-06 |
Frank Oakes
BRD | Director/Board Member | 73 | 10-04-08 |
Patrick Marshall
BRD | Director/Board Member | 53 | 23-05-22 |
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
-1.40% | 22.1B | |
-8.70% | 18.34B | |
-41.70% | 16.59B | |
-15.33% | 15.97B | |
+5.80% | 14.03B | |
+28.03% | 11.67B |